|
1
|
Favoriti P, Carbone G, Greco M, Pirozzi F,
Pirozzi RE and Corcione F: Worldwide burden of colorectal cancer: A
review. Updates Surg. 68:7–11. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Steeg PS: Targeting metastasis. Nat Rev
Cancer. 16:201–218. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Suliman HB and Piantadosi CA:
Mitochondrial quality control as a therapeutic target. Pharmacol
Rev. 68:20–48. 2016. View Article : Google Scholar
|
|
4
|
Scarpulla RC, Vega RB and Kelly DP:
Transcriptional integration of mitochondrial biogenesis. Trends
Endocrinol Metab. 23:459–466. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Biswas G, Guha M and Avadhani NG:
Mitochondria-to-nucleus stress signaling in mammalian cells: Nature
of nuclear gene targets, transcription regulation, and induced
resistance to apoptosis. Gene. 354:132–139. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
van Waveren C, Sun Y, Cheung HS and Moraes
CT: Oxidative phosphorylation dysfunction modulates expression of
extracellular matrix–remodeling genes and invasion. Carcinogenesis.
27:409–418. 2006. View Article : Google Scholar
|
|
7
|
Wang X and Moraes CT: Increases in
mitochondrial biogenesis impair carcinogenesis at multiple levels.
Mol Oncol. 5:399–409. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Liu W, Beck BH, Vaidya KS, Nash KT, Feeley
KP, Ballinger SW, Pounds KM, Denning WL, Diers AR, Landar A, et al:
Metastasis suppressor KISS1 seems to reverse the Warburg effect by
enhancing mitochondrial biogenesis. Cancer Res. 74:954–963. 2014.
View Article : Google Scholar
|
|
9
|
Mohan R and Grosshans D: Proton therapy -
Present and future. Adv Drug Deliv Rev. 109:26–44. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Fukuda K, Okumura T, Abei M, Fukumitsu N,
Ishige K, Mizumoto M, Hasegawa N, Numajiri H, Ohnishi K, Ishikawa
H, et al: Long-term outcomes of proton beam therapy in patients
with previously untreated hepatocellular carcinoma. Cancer Sci.
108:497–503. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Hatayama Y, Nakamura T, Suzuki M, Azami Y,
Ono T, Yabuuchi T, Hayashi Y, Kimura K, Hirose K, Wada H, et al:
Clinical outcomes and prognostic factors of high-dose proton beam
therapy for peripheral stage I non-Small-cell lung cancer. Clin
Lung Cancer. 17:427–432. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Yamoah K and Johnstone PA: Proton beam
therapy: Clinical utility and current status in prostate cancer.
Onco Targets Ther. 9:5721–5727. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Romesser PB, Cahlon O, Scher E, Zhou Y,
Berry SL, Rybkin A, Sine KM, Tang S, Sherman EJ, Wong R, et al:
Proton beam radiation therapy results in significantly reduced
toxicity compared with intensity-modulated radiation therapy for
head and neck tumors that require ipsilateral radiation. Radiother
Oncol. 118:286–292. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Ogata T, Teshima T, Kagawa K, Hishikawa Y,
Takahashi Y, Kawaguchi A, Suzumoto Y, Nojima K, Furusawa Y and
Matsuura N: Particle irradiation suppresses metastatic potential of
cancer cells. Cancer Res. 65:113–120. 2005.PubMed/NCBI
|
|
15
|
Narang H, Kumar A, Bhat N, Pandey BN and
Ghosh A: Effect of proton and gamma irradiation on human lung
carcinoma cells: Gene expression, cell cycle, cell death,
epithelial-mesenchymal transition and cancer-stem cell trait as
biological end points. Mutat Res. 780:35–46. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Nam KS, Kim MK and Shon YH: Cancer
chemopreventive enzymes of human colorectal adenocarcinoma cells
irradiated with proton beams. J Korean Phys Soc. 52:945–948. 2008.
View Article : Google Scholar
|
|
17
|
Nam KS and Shon YH: Suppression of
metastatic potential in human colorectal adenocarcinoma cells
irradiated with proton beams. J Korean Phys Soc. 59:709–712. 2011.
View Article : Google Scholar
|
|
18
|
Ha BG, Park JE, Cho HJ, Lim YB and Shon
YH: Inhibitory effects of proton beam irradiation on integrin
expression and signaling pathway in human colon carcinoma HT29
cells. Int J Oncol. 46:2621–2628. 2015.PubMed/NCBI
|
|
19
|
Kim B, Bae H, Lee H, Lee S, Park JC, Kim
KR and Kim SJ: Proton beams inhibit proliferation of breast cancer
cells by altering DNA methylation status. J Cancer. 7:344–352.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Ha BG, Park JE, Cho HJ and Shon YH:
Stimulatory effects of balanced deep sea water on mitochondrial
biogenesis and function. PLoS One. 10:e01299722015. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
MacDonald SM, DeLaney TF and Loeffler JS:
Proton beam radiation therapy. Cancer Invest. 24:199–208. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Wenz T: Regulation of mitochondrial
biogenesis and PGC-1α under cellular stress. Mitochondrion.
13:134–142. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Zhang Y and Xiang Y: Molecular and
cellular basis for the unique functioning of Nrf1, an indispensable
transcription factor for maintaining cell homoeostasis and organ
integrity. Biochem J. 473:961–1000. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Villena JA and Kralli A: ERRalpha: A
metabolic function for the oldest orphan. Trends Endocrinol Metab.
19:269–276. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Torrano V, Valcarcel-Jimenez L, Cortazar
AR, Liu X, Urosevic J, Castillo-Martin M, Fernández-Ruiz S,
Morciano G, Caro-Maldonado A, Guiu M, et al: The metabolic
co-regulator PGC1α suppresses prostate cancer metastasis. Nat Cell
Biol. 18:645–656. 2016. View
Article : Google Scholar : PubMed/NCBI
|
|
26
|
Luo C, Lim JH, Lee Y, Granter SR, Thomas
A, Vazquez F, Widlund HR and Puigserver P: A PGC1α-mediated
transcriptional axis suppresses melanoma metastasis. Nature.
537:422–426. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Hardie DG, Schaffer BE and Brunet A: AMPK:
An energy-sensing pathway with multiple inputs and outputs. Trends
Cell Biol. 26:190–201. 2016. View Article : Google Scholar
|
|
28
|
Gasparrini M, Giampieri F, Alvarez Suarez
JM, Mazzoni L, Y Forbes Hernandez T, Quiles JL, Bullon P and
Battino M: AMPK as a new attractive therapeutic target for disease
prevention: The role of dietary compounds AMPK and disease
prevention. Curr Drug Targets. 17:865–889. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Shackelford DB and Shaw RJ: The LKB1-AMPK
pathway: Metabolism and growth control in tumour suppression. Nat
Rev Cancer. 9:563–575. 2009. View
Article : Google Scholar : PubMed/NCBI
|
|
30
|
Chou CC, Lee KH, Lai IL, Wang D, Mo X,
Kulp SK, Shapiro CL and Chen CS: AMPK reverses the mesenchymal
phenotype of cancer cells by targeting the Akt-MDM2-Foxo3a
signaling axis. Cancer Res. 74:4783–4795. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Cerezo M, Tichet M, Abbe P, Ohanna M,
Lehraiki A, Rouaud F, Allegra M, Giacchero D, Bahadoran P,
Bertolotto C, et al: Metformin blocks melanoma invasion and
metastasis development in AMPK/p53-dependent manner. Mol Cancer
Ther. 12:1605–1615. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Rattan R, Graham RP, Maguire JL, Giri S
and Shridhar V: Metformin suppresses ovarian cancer growth and
metastasis with enhancement of cisplatin cytotoxicity in vivo.
Neoplasia. 13:483–491. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Kim HS, Kim MJ, Kim EJ, Yang Y, Lee MS and
Lim JS: Berberine-induced AMPK activation inhibits the metastatic
potential of melanoma cells via reduction of ERK activity and COX-2
protein expression. Biochem Pharmacol. 83:385–394. 2012. View Article : Google Scholar
|
|
34
|
Westermann B: Mitochondrial fusion and
fission in cell life and death. Nat Rev Mol Cell Biol. 11:872–884.
2010. View
Article : Google Scholar : PubMed/NCBI
|
|
35
|
Detmer SA and Chan DC: Functions and
dysfunctions of mitochondrial dynamics. Nat Rev Mol Cell Biol.
8:870–879. 2007. View
Article : Google Scholar : PubMed/NCBI
|
|
36
|
Mishra P: Interfaces between mitochondrial
dynamics and disease. Cell Calcium. 60:190–198. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Zhao J, Zhang J, Yu M, Xie Y, Huang Y,
Wolff DW, Abel PW and Tu Y: Mitochondrial dynamics regulates
migration and invasion of breast cancer cells. Oncogene.
32:4814–4824. 2013. View Article : Google Scholar
|
|
38
|
Chacinska A, Koehler CM, Milenkovic D,
Lithgow T and Pfanner N: Importing mitochondrial proteins:
Machineries and mechanisms. Cell. 138:628–644. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Madamba SM, Damri KN, Dejean LM and
Peixoto PM: Mitochondrial ion channels in cancer transformation.
Front Oncol. 5:1202015. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Sotgia F, Whitaker-Menezes D,
Martinez-Outschoorn UE, Salem AF, Tsirigos A, Lamb R, Sneddon S,
Hulit J, Howell A and Lisanti MP: Mitochondria 'fuel' breast cancer
metabolism: Fifteen markers of mitochondrial biogenesis label
epithelial cancer cells, but are excluded from adjacent stromal
cells. Cell Cycle. 11:4390–4401. 2012. View
Article : Google Scholar : PubMed/NCBI
|
|
41
|
Baker MJ, Frazier AE, Gulbis JM and Ryan
MT: Mitochondrial protein-import machinery: Correlating structure
with function. Trends Cell Biol. 17:456–464. 2007. View Article : Google Scholar : PubMed/NCBI
|
